K2 Oncology / OncoEngage LATAM
Clinical and strategic oncology intelligence
Real-world oncology intelligence
OncoEngage LATAM turns knowledge, data, experience and the reality of oncology care into practical conclusions for decision-making across the full life cycle of a drug: from its development to the moment it reaches the patient.
What is OncoEngage LATAM?
Clinical and strategic oncology intelligence for LATAM.
OncoEngage LATAM is the clinical and strategic intelligence unit of K2 Oncology. It integrates frontline medical expertise, knowledge of the health system, local data, networks of investigators and sites, biomarkers and the patient journey to answer critical industry questions in oncology.
Our focus is to close the gap between a global strategy and local clinical reality: how patients are diagnosed, how they are treated, where patients are, which biomarkers are used, which centers have real capacity and which barriers may affect development or adoption.
Who is it for?
- Pharma and biotech
- CROs and feasibility / site selection teams
- Medical Affairs
- Clinical Development
- Market Access
- Launch & Commercial Strategy
- Diagnostics and biomarker companies
We turn a fragmented local reality into actionable decisions
OncoEngage LATAM organizes and validates that information from the local clinical perspective to speed up decisions and reduce uncertainty in key areas such as:
01
Realistic size and distribution of oncology patient populations.
02
Current treatment practice and treatment sequencing.
03
Availability and real-world use of biomarkers.
04
Access, coverage and health system barriers.
05
Identification of investigators and centers with real capacity.
06
Clinical and operational feasibility of studies.
07
Patient journey and points of drop-off or delay.
08
Market readiness ahead of launch.
How we work
From the clinical question to the strategic recommendation.
Define the question
We start from a clearly defined clinical, development or market question.
Map the local reality
We integrate available data, clinical practice, access, biomarkers, centers and the patient journey.
Expert interpretation
Local oncologists and investigators interpret the information and validate its practical relevance.
Strategic synthesis
We turn findings into executive conclusions, scenarios and actionable recommendations.
Deliverable
The result is delivered in a concise, visual format that regional or global teams can use right away.
Our products
Disease Snapshot
A clinical and strategic snapshot of a disease in a given country or market.
PI & Site Map
A map of investigators and centers with real relevance in a given disease.
Feasibility Report
A clinical and operational assessment to determine the viability of a study in a country or network of centers.
Patient Journey
A representation of the patient's real journey from suspected diagnosis through treatment and follow-up.
Launch Readiness
An assessment of clinical and strategic readiness ahead of a therapy launch.
Biomarkers
They are incorporated across products when relevant, mainly within Disease Snapshot, Feasibility Report and Launch Readiness.
The analysis may include diagnostic availability, platforms used, turnaround times, access, coverage, testing penetration and gaps between recommendations and real-world practice.
OncoEngage Insight Report
An executive answer to a specific strategic question.
Integrates evidence, local data, clinical practice and expert opinion to deliver a concise, structured and actionable read.
Feasibility Report
A clinical and operational assessment to determine the viability of a study in a country or network of centers.
Analyzes eligible population, standard of care, competition, biomarkers, access, recruitment capacity and implementation barriers.
Patient Journey
A representation of the patient's real journey from suspected diagnosis through treatment and follow-up.
Identifies timelines, stakeholders, referrals, bottlenecks, patient drop-off and intervention points.
Why OncoEngage LATAM
Local expertise. Real context. Actionable intelligence.
Clinical approach
The analysis starts from oncologists and investigators who actively work with patients.
Local intelligence
We interpret the market's healthcare and clinical reality, not just secondary data.
Research network
Direct knowledge of investigators, sites, capabilities and recruitment dynamics.
Actionable deliverables
Executive deliverables designed to support concrete decisions.
AI + expert validation
We use AI to speed up search, structuring and analysis, with specialist interpretation and validation.
LATAM perspective
Initial focus on Chile and Argentina, with a methodology that scales to other markets in the region.
We are part of K2 Oncology
OncoEngage was born within K2 Oncology and draws on its experience in clinical oncology, research, feasibility and work with sponsors and CROs. This closeness makes it possible to understand not only market theory, but also the real operations of centers, investigators and patients.
K2 Oncology
Participates in and runs clinical studies.
OncoEngage
Delivers clinical and strategic intelligence to support decisions.
The challenges of OncoEngage LATAM
- How many truly eligible patients could there be for a study in Chile?
- Which centers have the real capacity to recruit a specific molecular population?
- How is this disease being treated today outside of the guidelines?
- What barriers affect access to biomarkers or new therapies?
- Where are patients lost along the diagnostic-therapeutic journey?
- Which PIs and sites should be prioritized for a feasibility assessment?
- Is the market ready for a new therapy or indication?
Contact us
What decision do you need to make?
Tell us your clinical question, tumor type and the country or market you are interested in. We design the deliverable to fit your goal and timeline.